Zelsuvmi 10.3 % Topical Gel
- RxCUI
- 2710443
- RxNorm name
- Zelsuvmi 10.3 % Topical Gel
- Display name
- Zelsuvmi 10.3 % Topical Gel
- Full name
- Zelsuvmi 10.3 % Topical Gel
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:04
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZELSUVMI | BERDAZIMER | LNHC, Inc. | 76b17622-bdb9-41ea-b962-c2acc0df71f7 | 2025-07-08 | Warnings, Adverse reactions | 2710443 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 76b17622-bdb9-41ea-b962-c2acc0df71f7 | Zelsuvmi 10.3 % Topical Gel [PSN] · berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] [SBD] · Zelsuvmi 0.103 MG/MG Topical Gel [SY] · Zelsuvmi 10.3 % Topical Gel [SY] | 4 | 3 | These highlights do not include all the information needed to use ZELSUVMI safely and effectively. See full prescribing information for ZELSUVMI. ZELSUVMI™ (berdazimer) topical gel Initial U.S. Approval: 2024 | 20250708 |